GABORONE, Feb. 2 (Xinhua) -- Botswana has adopted the use of long-acting antiretroviral injectables for HIV treatment, the country's Health Minister Edwin Dikoloti announced Thursday.
"We have, as a country, embraced a transformative leap in HIV care through the adoption of Long-Acting Antiretroviral Injectables, specifically Cabotegravir and Rilpivirine," said the minister when delivering a keynote at the four-day annual HIV/TB Summit in Francistown, the second largest city of Botswana.
